StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > the analyst had talked

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Apr 08, 2021 10:07am

95 Views

Post# 32956041

RE:the analyst had talked

More lies from Marcus.
The "Health Clinics deal has been in the works for about a year.
The Clarus analyst mistakenly thought that SZLS is no longer persuing employer avenues.
Tripp just explained very clearly that to get the "employer" connected market, they have to have clinical backup.
You don't tell an employee thay have a positive cancer test and just leave them high and dry, alone.
Well, Marcus would, if he had employees, lol. GLTA!

Marcus358 wrote: disspointed and feel frustrated the way TRIPP CHANGE THE PLAN. FROM 4$ TO 1.25$ A DECREASE OF 68%. FROM A BIG PARTNERSHIP TO BUYING A SMALL UNKNOWN CLINIC.

AMAZING......

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project